Comment
doi: 10.1016/S0140-6736(03)14996-3.
Are we ready for a paradigm change in cervical cancer screening?
Affiliations
- PMID: 14667737
- DOI: 10.1016/S0140-6736(03)14996-3
Item in Clipboard
Comment
Are we ready for a paradigm change in cervical cancer screening?
Lancet.
.
No abstract available
Comment on
-
Management of women who test positive for high-risk types of human papillomavirus: the HART study.Lancet. 2003 Dec 6;362(9399):1871-6. doi: 10.1016/S0140-6736(03)14955-0. Lancet. 2003. PMID: 14667741 Clinical Trial.
Similar articles
-
New guidelines on cervical cancer screening: more than just the end of annual Pap testing.J Low Genit Tract Dis. 2012 Jul;16(3):172-4. doi: 10.1097/LGT.0b013e31824bc178. J Low Genit Tract Dis. 2012. PMID: 22820979 Review. No abstract available.
-
[Cervical cancer screening. False negative smears].Rev Med Suisse Romande. 1997 Aug;117(8):597-601. Rev Med Suisse Romande. 1997. PMID: 9340714 Review. French. No abstract available.
-
[Screening of cervical cancer, false negative vaginal smears].Rev Med Suisse Romande. 1997 Nov;117(11):921. Rev Med Suisse Romande. 1997. PMID: 9471658 French. No abstract available.
-
The pitfalls of cervical cancer screening.Contrib Gynecol Obstet. 1991;18:103-14. Contrib Gynecol Obstet. 1991. PMID: 1657521 Review. No abstract available.
-
Vaginal Pap tests status-post hysterectomy.Diagn Cytopathol. 2007 Aug;35(8):539-40. doi: 10.1002/dc.20691. Diagn Cytopathol. 2007. PMID: 17636499 No abstract available.
Cited by
-
The lysine acetyltransferase GCN5 contributes to human papillomavirus oncoprotein E7-induced cell proliferation via up-regulating E2F1.J Cell Mol Med. 2018 Nov;22(11):5333-5345. doi: 10.1111/jcmm.13806. Epub 2018 Aug 6. J Cell Mol Med. 2018. PMID: 30079588 Free PMC article.
